Oral cyclophosphamide improves pulmonary function in scleroderma patients with fibrosing alveolitis: experience in one centre (Q83154992)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614793%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Oral cyclophosphamide improves pulmonary function in scleroderma patients with fibrosing alveolitis: experience in one centre (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614793%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Lorenzo Beretta

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614793%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Monica Caronni

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614793%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Massimo Raimondi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614793%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Alessandra Ponti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614793%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Tiziana Viscuso

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614793%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Laura Origgi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614793%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Raffaella Scorza

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614793%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

14 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614793%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

published in

Clinical Rheumatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614793%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614793%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614793%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

168-172

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614793%20AND%20SRC:MED&resulttype=core&format=json

Structural features of interstitial lung disease in systemic sclerosis

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10067-006-0254-X

Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-006-0254-X

Fibrosing alveolitis in systemic sclerosis. Bronchoalveolar lavage findings in relation to computed tomographic appearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-006-0254-X

American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique--1995 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-006-0254-X

Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-006-0254-X

Idiopathic pulmonary fibrosis: predicting response to therapy and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-006-0254-X

Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study

21 January 2018

1 reference

12 December 2020

Intravenous cyclophosphamide pulse therapy for the treatment of lung disease associated with scleroderma

1 reference

12 December 2020

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

1 reference

12 December 2020

Clinical aspects of systemic sclerosis (scleroderma)

1 reference

12 December 2020

Clinical usefulness of the single-breath pulmonucy diffusing capacity test

1 reference

12 December 2020

Predictors of survival in systemic sclerosis (scleroderma)

1 reference

12 December 2020

Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide

1 reference

12 December 2020

High resolution computed tomography as a predictor of lung histology in systemic sclerosis

1 reference

12 December 2020

Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.

1 reference

12 December 2020

Cyclophosphamide with low or high dose prednisolone for systemic sclerosis lung disease.

1 reference

12 December 2020

Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis.

1 reference

12 December 2020

Respiratory function tests; normal values at median altitudes and the prediction of normal results

1 reference

12 December 2020

Evaluation and management of scleroderma lung disease using bronchoalveolar lavage

1 reference

12 December 2020

Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis

1 reference

12 December 2020

A pilot study of intermittent intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung disease

1 reference

12 December 2020

Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease

1 reference

12 December 2020

Severe organ involvement in systemic sclerosis with diffuse scleroderma

1 reference

12 December 2020

10.1007/S10067-006-0254-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614793%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference